Elkem (ELK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Sale of Silicones division to Bluestar closing 30 April 2026, transforming the company into a pure-play metals and materials business and sharpening strategic focus.
NOK 1.5 billion equity raise and EUR 1 billion fully underwritten debt refinancing secured to strengthen the balance sheet.
Significant cost reduction program underway, targeting NOK 600 million in annual savings and a 10% workforce reduction by year-end 2026.
Reorganization into three divisions: Silicon, Foundry Alloys, and Carbon, with new management appointments and CEO to become chairman.
Challenging market conditions persist due to trade regulations and geopolitical uncertainty.
Financial highlights
Q1 2026 operating income (excluding Silicones) was NOK 4,053 million, down 7% year-over-year.
Q1 2026 EBITDA was NOK 249 million, down 65% year-over-year, with a 6% EBITDA margin.
Silicon Products EBITDA fell 75% to NOK 122 million; Carbon Solutions EBITDA down 37% to NOK 165 million.
EPS for Q1 2026 was NOK 0.56 per share; equity ratio at 42%, pro forma 46% after equity raise.
Net interest-bearing debt at NOK 9,275 million; leverage ratio 5x EBITDA, pro forma 4x after equity raise.
Outlook and guidance
Market conditions remain challenging with low visibility due to trade regulations, geopolitical uncertainty, and Middle East conflict.
Gradual improvement expected as production returns to full capacity; Q2 profitability to improve but not yet at normal levels.
Silicon Products expected to see gradual improvement; Carbon Solutions anticipates stable performance.
Working capital reduction of NOK 1 billion targeted for 2024, with most realized in Q2.
Cost reduction program to deliver half of NOK 600 million savings by end of 2026.
Latest events from Elkem
- Portfolio reshaping and cost cuts position the company for focused growth amid market challenges.ELK
DNB Carnegie Small & Medium Enterprises Conference presentation30 Mar 2026 - Silicones division sale drives transformation, cost cuts, and growth focus amid challenging markets.ELK
JP Morgan European Chemicals Forum presentation30 Mar 2026 - All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 20269 Mar 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 202418 Jan 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026 - Stable results amid weak markets, with Silicones improving and strategic review ongoing.ELK
Lunch presentation14 Jan 2026